Maxim Group Reiterates Buy on HeartSciences, Maintains $12 Price Target

BenzingaDec 18 22:20 · Ratings

HeartSciences Analyst Ratings

BenzingaDec 18 22:19 · Ratings

Heart Test Laboratories Q2 EPS $(2.27) Beats $(2.43) Estimate

BenzingaDec 17 05:25

HeartSciences: Saw Across-the-Bd Progress, Positive Developments for Field of AI-ECG, MyoVista WavECG Device, MyoVista Insights Cloud-Native Platform and First Cloud-Based AI-ECG Algorithms >HSCS

Dow JonesDec 17 05:23

HeartSciences: No Rev During 2Q FY25. as of Oct 31, 2024, Cash and Cash Equivalents Were Approximately $4.1M and Shareholders' Equity Was Approximately $4.0M >HSCS

Dow JonesDec 17 05:23

8-K: HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

SECDec 17 05:18 · Announcements